CELG-RI
Bristol-Myers Squibb Company Ce
NYSE · Healthcare · Drug Manufacturers - General · US
$0.14
−6.69%Leverage
- Debt / equity
- 2.31x
- Net debt / equity
- 1.84x
- Debt / assets
- 0.54x
- Debt / EBITDA
- 2.52x
- Net debt / EBITDA
- 2.00x
Liquidity & coverage
- Current ratio
- 1.42x
- Quick ratio
- 1.28x
- Cash ratio
- 0.55x
- Interest coverage
- 8.50x
- EBITDA / interest
- 10.21x
- Working capital
- $8.1B
Cash & dividend
- FCF / debt
- 0.26x
- Cash flow / debt
- 0.29x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -81.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026